The COVID-19 Drugs market refers to the global industry dedicated to the research, development, and distribution of pharmaceuticals aimed at treating and preventing COVID-19. As the COVID-19 Drugs market size continues to evolve, understanding its growth outlook, market forecast, and industry expansion is crucial for strategic decision-making. The scope of this market encompasses a broad range of therapeutic agents, including antiviral drugs, immunomodulators, and vaccines, highlighting the complexity and competitive landscape of the industry. With a current market size of approximately $13.5 billion, the COVID-19 Drugs market is poised for significant growth, driven by factors such as the ongoing pandemic, advancements in medical technology, and increasing demand for effective treatments. The market is expected to experience a Compound Annual Growth Rate (CAGR) of around 12.5%, with key drivers including technology shifts, stringent regulations, and changing consumer behavior.